FDA Data MCP
☰
Docs
Datasets
Pricing
Blog
Account
Statistics
Get API Key
Home
/
Import refusals
/ NUV-3852229-1/20002/1
NUV-3852229-1/20002/1
Eli Lilly & Company — FEI 1819470
Recent inspections
1298628
(NAI Fri Jan 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
1270621
(VAI Tue May 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
1260339
(VAI Thu Mar 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
1229895
(NAI Wed Jan 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
1217806
(VAI Fri Sep 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
Compliance actions
Warning Letter (716485)
(Tue Sep 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
Warning Letter (716475)
(Tue Sep 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
Warning Letter (716462)
(Tue Sep 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
Other import refusals
799-3629208-1/20001/1
(Thu Mar 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
799-3862393-4/10001/1
(Wed Jan 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
799-0166087-1/20001/1
(Thu Nov 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
NUV-3849643-9/30002/1
(Tue Nov 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
NUV-3852229-1/10002/1
(Tue Nov 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
Refusal Details
Date
November 4, 2025
Country
United States
Product Category
Drugs and Biologics
Product Code
58HCP09 INSULIN GLARGINE
Charges
179